Stock News Buzz: Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. (NASDAQ:TRPX) changed 32.91% to recent value of $0.43. The stock transacted 313244 shares during most recent day however it has an average volume of 226.21K shares. It spotted trading -90.83% off 52-week high price. On the other end, the stock has been noted 50.86% away from the low price over the last 52-weeks.

On March 19,2020, Therapix Biosciences Ltd. (NASDAQ:TRPX) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments reported that it has entered into a securities purchase agreement pursuant to which it will make a private placement (the Private Placement) to its Chairman and Interim Chief Executive officer of convertible promissory notes (the Notes) with an aggregate original principal amount of approximately $350,000 (the Principal Amount), at an aggregate purchase price of $315,000 (the Purchase Price) in several tranches, spread across a 12 month period. In addition, the Company will issue a warrant to purchase up to 314,285 American Depositary Shares (ADSs) of the Company (the Warrant) and 40,000 ADSs. The initial tranche of the Private Placement is for a Principal Amount of $220,000 at a Purchase Price of $198,000.

The Private Placement is expected to close on March 23, 2020, subject to customary closing conditions.

The Notes will be unsecured, have a maturity date of March 18, 2021, bear interest at a rate of 12% per annum, and may be converted, at the election of the holder, into ADS at an initial conversion price of $0.35 per ADS (the Fixed Conversion Price), subject to adjustments. After the six month anniversary of the issuance of the Notes, the conversion price shall be equal to the lower of the Fixed Conversion Price or 70% of the lowest trading price of the ADSs as reported on the Nasdaq Capital Market or any exchange upon which the ADSs or ordinary shares of the Company are traded at such time, for the 20 prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent.

. Its earnings per share (EPS) expected to touch remained -12.20% for this year.

The company has 38.89M of outstanding shares and 3.46M shares were floated in the market. According to the most recent quarter its current ratio was 0.5 that represents company’s ability to meet its current financial obligations. The price moved ahead of -2.89% from the mean of 20 days, -21.24% from mean of 50 days SMA and performed -76.01% from mean of 200 days price. Company’s performance for the week was 18.03%, -13.98% for month and YTD performance remained -61.46%.

Edward Hancock

Edward Hancock holds Master’s degree in Business Administration. After completing his post-graduation, Edward jumped the journalism bandwagon as a freelance news writer. Soon after that he landed a job of reporter and has been climbing the news industry ladder ever since to reach the post of editor. As an avid day trader, Edward is a master of technical analysis and writes tirelessly on how stocks are trading. He has extensive knowledge in technical analysis & news writing. Edward delivers news reports regarding Trending news category.

Email: [email protected]

Address: 3908 Scenic Way, Elliottstown City, IL 62424, USA

Contact number: 217-739-2075

Leave a Reply

Your email address will not be published.